Profound Medical Corp (PROF): Enterprise Value to EBITDA Ratio
Profit-oriented Profound Medical Corp. (PROF) is developing the innovative TULSA technology, offering urologists an alternative to the traditional scalpel and radiation. This chart of the valuation on the GURU.Markets platform shows EV/EBITDA at 0.00, which correlates with the active implementation of TULSA-PRO systems. The business's success relies on physician recognition of the method, the expansion of insurance reimbursements, and the number of installed devices in medical centers.
Comprehensive metric breakdowns and analytics for profoundmedical.com (PROF)
- stock price and consensus target price:
- stock exchange capitalization data:
- business book valuation details:
- debt obligations and liquidity statistics:
Total Debt to Equity Ratio Profound Medical Corp.|PROF - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity Profound Medical|PROF - Company Total Debt|Debts to Book Capitalization Profound Medical Corp.|PROF - Long-Term Debt|Company Short-Term Debts Profound Medical|Quick Ratio profoundmedical.com
- financial results and valuation multiples details:
PROF - Net Financial Result|Projected Future Earnings Profound Medical Corp.|PROF - Price to Earnings Ratio|Forward P/E Multiple Profound Medical|PROF - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Profound Medical Corp.|PROF - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Profound Medical|PROF - Earnings per share for the trailing year|Quarterly EPS earnings growth profoundmedical.com|PROF - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Profound Medical Corp.
Analysis of all company metrics:Profound Medical Corporation PROF
Scaling sales of disposable modules at Profound Medical Corp. (PROF) creates operating leverage that reduces the impact of fixed costs. The EV/EBITDA multiple compares the total enterprise value with its operating profit before taxes and depreciation, neutralizing differences in capital structure. This metric allows for an assessment of the company's resilience to debt load and determines the fair value of assets. By analyzing the EV/EBITDA dynamics of the business, an investor can timely identify a local bottom and avoid value traps.
Competitor analysis
Dexcom Corp - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple Penumbra Medical PEN|NOVT: Enterprise Value to EBITDA Ratio|haemonetics.com - Enterprise Value to Operating Income Before Depreciation Ratio|INSP: EV/EBITDA Multiple|PRCT - Total Company Value to Operating Income Before Depreciation Ratio|CNMD (CONMED Corp.) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Pulse Medical (PLSE)|Enterprise Value to EBITDA Ratio INMD (InMode Ltd.)|PMI (picardmedical.com) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Surmodics SRDX|SENS - Enterprise Value to EBITDA Ratio|NeuroPace Corp - EV/EBITDA Multiple|Company Value to EBITDA Tactile Systems Technology|SNWV: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation OM|ELMD (SmartVest) - EV/EBITDA Multiple|LENSAR Inc. (LNSR) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple RCEL|Enterprise Value to EBITDA Ratio bairdmed.com BDMD|EV/EBITDA Multiple EDAP (EDAP TMS)|EV/EBITDA Multiple Apyx Medical Corp APYX|ICCM - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|LUNG: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|TELA (telabio.com) - Enterprise Value to EBITDA Ratio|CytoSorbents Corporation - Business Value to Operating Income Before Depreciation|SRTS (Sensus Healthcare, Inc.) - EV/EBITDA Multiple|Company Value to EBITDA zynex.com ZYXI|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization electroCore, Inc. (ECOR)|vicarioussurgical.com (RBOT) - Enterprise Value to EBITDA Multiple|Inspira Technologies - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple SeaStar Medical Holding Corp. ICU|IRIDEX Corp. - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Intelligent Bio Solutions INBS|beyondair.net (XAIR) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio PFSA (Profusa Inc.)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization STRATA Skin Sciences Inc.|Enterprise Value to EBITDA Ratio GlucoTrack Inc. (GCTK)|EV/EBITDA Multiple NAOV|VERO - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Nuwellis NUWE|AEMD: Enterprise Value to Operating Income Before Depreciation|ASXC: Enterprise Value to EBITDA Ratio|Avinger Inc - Enterprise Value to Operating Income Before Depreciation Ratio|BioSig Technologies, Inc. (BSGM) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio CUTR (cutera.com)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Know Labs|NARI: Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Nevro Corporation (NVRO)|RSLS - Company Value to EBITDA|EV/EBITDA Multiple SILK (Silk Road Medical, Inc)
